The bone-protective effect of the phytoestrogen genistein is mediated via ERα-dependent mechanisms and strongly enhanced by physical activity
Introduction
Growth, differentiation and functioning of many typical tissues of the female reproductive tract like uterus, ovary and the mammary gland are influenced by estradiol. Estrogens also play an important role in bone maintenance [1], [2] and in the cardiovascular system where they have certain cardioprotective effects [3]. Reduced estrogen levels occurring in menopausal and postmenopausal women are accompanied by a variety of disorders, e.g. hot flushes, depressions, osteoporosis, increase in body weight and reduced movement drive. As a therapeutic strategy, hormone replacement therapy (HRT) has been used for decades as the “gold standard” to treat estrogen deficiency symptoms such as vasomotor disturbances and genito-urinary atrophy [4]. In addition, use of HRT prevents long-term development of postmenopausal osteoporosis [5], [6]. Recently, the data from the Million Women Study [7] have once again opened up the discussion about the benefit/risk ratio of HRT and alternative strategies for the treatment of menopausal and postmenopausal disorders. Besides the use of selective estrogen receptor modulators (SERMs) [8], [9] the use of ER subtype-specific ligands is discussed to be useful in HRT, too. Cloning of a second estrogen receptor in the rat prostate in 1996 led to the description of ERβ [10]. Thus, estrogen receptor signaling has become much more complex and multifaceted [11], [12], [13]. Even though estrogens bind with similar affinity to estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) [14], the ligand-binding domains (LBD) of these two transcription factors differ significantly from each other [15].
Unlike E2, several synthetic ER ligands like Tamoxifen (Tam), Raloxifene (Ral), or other SERMs exhibit a distinct binding affinity to ERα and ERβ [16], [17], [18]. There are speculations that the molecular mechanisms involved in the tissue-selective action of theses substances include ER subtype-specific effects [19], [20]. Moreover, the effects of some phytoestrogens, compounds of plant origin with affinity to the ER, are discussed to be mediated via ER subtype-specific mechanisms [21].
The phytoestrogen GEN, for example, is supposed to function as an ERβ-selective partial agonist, which binds to the LBD of both ER isoforms with moderate affinity [15], [22], but preferentially to ERβ and in a manner similar to E2[23]. These differences in binding activities suggest that phytoestrogens like GEN may selectively trigger ERβ-mediated transcriptional pathways [21].
In the context of different menopausal and postmenopausal disorders information on the tissue specific action of estrogens and phytoestrogens associated with specific estrogen receptor signaling is very limited. The identification of isotype-selective ER ligands provides an alternative tool to study the biological role of ERα and ERβ adding to the information generated by the analysis of ER knockout animals. The studies shown in the present paper have been performed with the novel highly selective steroidal ERβ agonist 8β-VE2[24], and the highly selective ERα agonist 16α-LE2[25], [26], which belong to the most potent and isotype-selective estrogens identified so far.
Therefore, the aim of this study was to investigate if observed impacts of the phytoestrogen GEN on menopausal disorders are based upon its property as a weak ERα or as a potent ERβ agonist.
Section snippets
Substances
17β-Estradiol (estra-1,3,5(10)-trien-3,16α,17β-diol), and genistein (4′,5,7-trihydroxyisoflavone) were provided by Sigma-Aldrich (Deisenhofen, Germany). The specific estrogen receptor agonists ALPHA (16α-LE2, 3,17-dihydroxy-19-nor-17α-pregna-1,3,5 (10)-triene-21,16α-lactone) and BETA (8β-VE2, 8-vinylestra-1,3,5 (10)-triene-3,17β-diol) and the pure antiestrogen Faslodex (ICI) were provided by Schering AG (Berlin, Germany).
Diet
All rats had free access to a diet low in phytoestrogen content (ILD)
Estrogen receptor-specific effects on uterus and body weight
To study the effects of specific estrogen receptor agonists (Fig. 1) and of the phytoestrogen genistein on uterine wet weights (Fig. 2) and the thickness of the uterine epithelium (data not shown), ovariectomized female Wistar rats were randomly divided into 7 groups (n = 5). The animals were treated with 17β-estradiol (E2) (4 μg/kg/day), the ERα-specific agonist (ALPHA) 16α-LE2 (10 μg/kg/day), the ERβ-specific agonist (BETA) 8β-VE2 (100 μg/kg/day), the phytoestrogen genistein (GEN)
Discussion
The major findings of the presented study demonstrate that E2 and ALPHA treatment significantly increased the movement activity of OVX rats. Bone mineral density and the expression of BMP-2 were significantly reduced in OVX- and BETA-treated rats as compared to E2-, ALPHA- and GEN-treated animals. GEN has no bone-protective activity in the absence of physical activity. These findings are in our opinion highly relevant for the understanding of the molecular mechanisms involved in several
References (46)
- et al.
The role of estrogen in cardiovascular disease
J. Surg. Res.
(2003) - et al.
The menopause
Lancet
(1999) - et al.
Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs)
Best Pract. Res. Clin. Endocrinol. Metab.
(2004) An update on estrogen receptors
Semin. Perinatol.
(2000)What pharmacologists can learn from recent advances in estrogen signalling
Trends Pharmacol. Sci.
(2003)Tissue-specific estrogenic response and molecular mechanisms
Toxicol. Lett.
(2002)Phytoestrogens–mechanism of action and effect on bone markers and bone mineral density
Endocrinol. Metab. Clin. N. Am.
(2003)- et al.
The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression
Mol. Cell. Endocrinol.
(2004) - et al.
Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens
Mol. Cell. Endocrinol.
(2005) - et al.
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice
Biochem. Biophys. Res. Commun.
(2000)
Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice
Curr. Opin. Pharmacol.
Effects of the phytoestrogen coumestrol on locomotor and fear-related behaviors in female mice
Horm. Behav.
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Am. J. Clin. Nutr.
Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production
Biochem. Pharmacol.
Skeletal effects of estrogen
Endocr. Rev.
Sex steroids and the construction and conservation of the adult skeleton
Endocr. Rev.
17 beta-Estradiol for postmenopausal estrogen replacement therapy
Obstet. Gynecol. Surv.
Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Swedish Hip Fracture Study Group
Osteoporos. Int.
Breast cancer and hormone-replacement therapy in the Million Women Study
Lancet
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years
Menopause
Cloning of a novel receptor expressed in rat prostate and ovary
Proc. Natl. Acad. Sci. U. S. A.
Reflections on the discovery and significance of estrogen receptor beta
Endocr. Rev.
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
Endocrinology
Cited by (79)
Isoflavones isolated from chickpea sprouts alleviate ovariectomy-induced osteoporosis in rats by dual regulation of bone remodeling
2024, Biomedicine and PharmacotherapyAmelioration of postmenopausal osteoporosis and anticancer properties of an antioxidant enriched fraction from Hygrophila spinosa T. Anders
2018, South African Journal of BotanyCombinatory effects of phytoestrogens and exercise on body fat mass and lipid metabolism in ovariectomized female rats
2018, Journal of Steroid Biochemistry and Molecular BiologyEffects of estradiol, estrogen receptor subtype-selective agonists and genistein on glucose metabolism in leptin resistant female Zucker diabetic fatty (ZDF) rats
2015, Journal of Steroid Biochemistry and Molecular Biology